Cargando…

Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging

SIMPLE SUMMARY: The childhood tumor, neuroblastoma, has a broad clinical presentation. Risk assessment at diagnosis is particularly difficult in molecularly heterogeneous high-risk cases. Here we investigate the potential of imaging mass spectrometry to directly detect intratumor heterogeneity on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhiyang, Hundsdoerfer, Patrick, Schulte, Johannes H., Astrahantseff, Kathy, Boral, Senguel, Schmelz, Karin, Eggert, Angelika, Klein, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269054/ https://www.ncbi.nlm.nih.gov/pubmed/34202325 http://dx.doi.org/10.3390/cancers13133184

Ejemplares similares

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions
por: Schmelz, Karin, et al.
Publicado: (2021)

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
por: Arnhold, Viktor, et al.
Publicado: (2017)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging
por: Loch, Florian N., et al.
Publicado: (2021)

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2017)

MALDI Imaging Mass Spectrometry (MALDI-IMS)—Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis
por: Gustafsson, Johan O. R., et al.
Publicado: (2011)

Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling
por: Conraux, Laurence, et al.
Publicado: (2013)

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
por: Fuchs, Steffen, et al.
Publicado: (2023)

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
por: Pajtler, Kristian W, et al.
Publicado: (2016)

In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging
por: Grzeski, Marta, et al.
Publicado: (2022)

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics
por: Lodrini, Marco, et al.
Publicado: (2022)

Use of MALDI Mass Spectrometry Imaging to Identify Proteomic Signatures in Aortic Aneurysms after Endovascular Repair
por: Buerger, Matthias, et al.
Publicado: (2021)

OR19-06 State-of-the-art MALDI Mass Spectrometry Imaging Reveals Unique Spatial Lipid Signatures in Human and Mouse Ovarian Compartments
por: Pascuali, Natalia, et al.
Publicado: (2023)

Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect
por: Arlt, Birte, et al.
Publicado: (2021)

Characterizing lysinoalanine crosslinks in food systems: Discovery of a diagnostic ion in model peptides using MALDI mass spectrometry
por: McKerchar, Hannah, et al.
Publicado: (2023)

Targeting tachykinin receptors in neuroblastoma
por: Henssen, Anton G., et al.
Publicado: (2016)

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
por: Szymansky, Annabell, et al.
Publicado: (2021)

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
por: Althoff, K, et al.
Publicado: (2015)

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
por: Kulbe, Hagen, et al.
Publicado: (2020)

Tiffany Porta Siegel (Ed.): MALDI mass spectrometry imaging: from fundamentals to spatial omics
por: Strittmatter, Nicole
Publicado: (2022)

Bacteria spatial tracking in Urban Park soils with MALDI-TOF Mass Spectrometry and Specific PCR
por: Arnal, Diego, et al.
Publicado: (2023)

Peptide Sequencing Directly on Solid Surfaces Using MALDI Mass Spectrometry
por: Zhao, Zhan-Gong, et al.
Publicado: (2017)

Mass-Up: an all-in-one open software application for MALDI-TOF mass spectrometry knowledge discovery
por: López-Fernández, H., et al.
Publicado: (2015)

A Moldy Application of MALDI: MALDI-ToF Mass Spectrometry for Fungal Identification
por: Patel, Robin
Publicado: (2019)

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model
por: Ivasko, Sara Marie, et al.
Publicado: (2023)

Batch Effects in MALDI Mass Spectrometry Imaging
por: Balluff, Benjamin, et al.
Publicado: (2021)

Performance of MALDI–TOF Mass Spectrometry in the Philippines
por: Osa, Morichika, et al.
Publicado: (2021)

Visualizing the Spatial Distribution of Arctium lappa L. Root Components by MALDI-TOF Mass Spectrometry Imaging
por: Li, Lingyu, et al.
Publicado: (2022)

Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis
por: Sulejmani, Ornela, et al.
Publicado: (2021)

Analysis of RNA cleavage by MALDI-TOF mass spectrometry
por: Joyner, Jeff C., et al.
Publicado: (2013)

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
por: Hanrieder, Jörg, et al.
Publicado: (2012)

Rapid MALDI mass spectrometry imaging for surgical pathology
por: Basu, Sankha S., et al.
Publicado: (2019)

Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications
por: Ng, Eddy W. Y., et al.
Publicado: (2013)

Application of MALDI-TOF Mass Spectrometry in Clinical Virology
por: Camarasa, Cristina Gómez, et al.
Publicado: (2018)

MALDI-TOF Mass Spectrometry in Clinical Analysis and Research
por: Li, Dandan, et al.
Publicado: (2022)

MALDI-TOF Mass Spectrometry for interrogating ubiquitin enzymes
por: De Cesare, Virginia
Publicado: (2023)

MALDI-2 Mass Spectrometry for Synthetic Polymer Analysis
por: Molina-Millán, Lidia, et al.
Publicado: (2023)

A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature)
por: Yang, Xinan (Holly), et al.
Publicado: (2017)

Mapping the Lipids of Skin Sebaceous Glands and Hair Follicles by High Spatial Resolution MALDI Imaging Mass Spectrometry
por: Xie, Fang, et al.
Publicado: (2022)

Quantifying the Matrix Metalloproteinase 2 (MMP2) Spatially in Tissues by Probe via MALDI Imaging Mass Spectrometry
por: Yu, Daojiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0shefs3h3fjvit14dvjvf9c0os